Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Medical Oncology
Published in: Medical Oncology 4/2010

01-12-2010 | Original Paper

An unusual presentation of extramedullary plasmacytoma in testis and review of the literature

Authors: H. Mehmet Turk, Seref Komurcu, Ahmet Ozet, Okan Kuzhan, Ömer Günhan

Published in: Medical Oncology | Issue 4/2010

Login to get access

Abstract

Extramedullary plasmacytoma is a rare plasma cell neoplasm, and it is extremely uncommon in the testicles. We report a 73-year-old man with multiple myeloma presented with testicular plasmacytoma. He complained of left leg pain and scrotal swelling. Ultrasonography revealed testicular masses. Pathologic examination of the orchiectomy specimen showed plasmocytoma with kappa expression. Multiple lytic bone lesions were seen in bone survey scans, serum immunoelectrophoresis and bone marrow aspiration aided to the diagnosis of multiple myeloma. He received chemotherapy, melphalan and prednisolone, and palliative radiotherapy. He succumbed to disease after 8 months.
Literature
1.
Soutar R, Lucraft H, Jackson G, Reece A, Bird J, Low E. Samson D; Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Br J Haematol. 2004;124(6):717–26.CrossRefPubMed
2.
Shih LY, Dunn P, Leung WM, Chen WJ, Wang PN. Localised plasmacytomas in Taiwan:comparison between extramedullary plasmacytoma and solitary plasmacytoma of bone. Br J Cancer. 1995;71(1):128–33.PubMed
3.
Alexiou C, Kau RJ, Dietzfelbinger H, Kremer M, Spiess JC, Schratzenstaller B, et al. Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts. Cancer. 1999;85(11):2305–14.CrossRefPubMed
4.
Strojan P, Soba E, Lamovec J, Munda A. Extramedullary plasmacytoma: clinical and histopathologic study. Int J Radiat Oncol Biol Phys. 2002;53(3):692–701.CrossRefPubMed
5.
Kyte RA, Greipp PA. Plasma cell dyscrasias: current status. Crit Rev Oncol Hematol. 1998;8:93–152.
6.
Tsang RW, Gospodarowicz MK, Pintilie M, Bezjak A, Wells W, Hodgson DC, et al. Solitary plasmacytoma treated with radiotherapy impact of tumor size on outcome. Int J Radiat Oncol Biol Phys. 2001;50(1):113–20.CrossRefPubMed
7.
8.
Hayes DW, Bennett WA, Heck FJ. Extramedullary lesions in multiple myeloma; review of literature and pathologic studies. AMA Arch Pathol. 1952;53(3):262–72.PubMed
9.
Gowing NF. Malignant lymphoma of the testis. Br J Urol. 1964;36(Suppl):85–94.PubMed
10.
Chica G, Johnson DE, Ayala AG. Plasmacytoma of testis presenting as primary testicular tumor. Urology. 1978;11(1):90–2.CrossRefPubMed
11.
Oppenheim PI, Cohen S, Anders KH. Testicular plasmacytoma: a case report with immunohistochemical studies and literature review. Arch Pathol Lab Med. 1991;115(6):629–32.PubMed
12.
Anghel G, Petti N, Remotti D, Ruscio C, Blandino F, Majolino I. Testicular plasmacytoma: report of a case and review of the literature. Am J Hematol. 2002;71(2):98–104.CrossRefPubMed
13.
14.
Avitable AM, Gansler TS, Tomaszevski JE, Hanno P, Goldwein MI. Testicular plasmacytoma. Urology. 1989;34(1):51–4.CrossRefPubMed
15.
Mayr NA, Wen BC, Hussey DH, Burns CP, Staples JJ, Doornbos JF, et al. The role of radiation therapy in the treatment of solitary plasmacytoma. Radiother Oncol. 1990;17(4):293–303.CrossRefPubMed
Metadata
Title
An unusual presentation of extramedullary plasmacytoma in testis and review of the literature
Authors
H. Mehmet Turk
Seref Komurcu
Ahmet Ozet
Okan Kuzhan
Ömer Günhan
Publication date
01-12-2010
Publisher
Springer US
Published in
Medical Oncology / Issue 4/2010
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-009-9390-x

Other articles of this Issue 4/2010

Medical Oncology 4/2010 Go to the issue

Original Paper

Discovery of a set of biomarkers of human lung adenocarcinoma through cell-map proteomics and bioinformatics

Letter to the Editor

Other malignancies in patients with breast cancer: a single institute experience

Case Report

Acute renal failure related to oxaliplatin-induced intravascular hemolysis

original paper

Port central venous catheters–associated bloodstream infection during outpatient-based chemotherapy

Original Paper

Clinical significance of vascular endothelial growth factor and connexin43 for predicting pancreatic cancer clinicopathologic parameters

Original Paper

Regression of advanced melanoma upon withdrawal of immunosuppression: case series and literature review
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits